Category

Blastoma

The Cancer Custodians Blastoma

The Cancer Custodians

Part of Dennis Plenker’s daily job is growing cancer. And a variety of different ones, too. Depending on the day and the project, different tumors may burgeon in the petri dishes stocked in the Cold Spring Harbor Laboratory where Plenker works as a research investigator. They might be aggressive breast…
bubmag
June 23, 2021
Limited edition bracelet to help little warriors fighting rare childhood cancer Blastoma

Limited edition bracelet to help little warriors fighting rare childhood cancer

South of the River, a small fashion boutique based in Beckenham, Kent, is supporting Neuroblastoma UK, a national children’s cancer charity this summer with a limited edition ‘Warrior’ Tile Bracelet. Inspired by children with cancer and designed in collaboration with Neuroblastoma UK, each bracelet features white ‘Warrior’ tiles on a…
bubmag
June 1, 2021
Oncotarget: Piperlongumine promotes death of retinoblastoma cancer cells Blastoma

Oncotarget: Piperlongumine promotes death of retinoblastoma cancer cells

IMAGE: Effects of PL on cell cycle-regulatory factors in WERI-Rb and Y79 cells. (A) The expression of CDC25C, CDK1, CCNA2, CCNB1, CDKN1A and CDKN1B was measured at mRNA levels using real... view more  Credit: Correspondence to - Nathalie Allaman-Pillet - nathalie.allaman@gmail.com Oncotarget published "Piperlongumine promotes death of retinoblastoma cancer cells" which…
bubmag
May 31, 2021
Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications Blastoma

Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications

Home Press release May 07, 2021 11:08 JST Source: Eisai Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications For Advanced Renal Cell Carcinoma and for Advanced Endometrial CarcinomaApplications Based on Progression-Free Survival, Overall Survival, and Objective Response…
bubmag
May 7, 2021
New drug targets for childhood cancer neuroblastoma identified Blastoma

New drug targets for childhood cancer neuroblastoma identified

The largest single cell study to date of the childhood cancer, neuroblastoma, has answered important questions about the genesis of the disease. The researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital (GOSH) and the Princess Máxima Center for Pediatric Oncology, discovered that all neuroblastomas arise from a single…
bubmag
February 5, 2021